Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Primary Care Opioid Taper Plans and Their Components on Sustained Opioid Taper and Opioid Discontinuation

NCT03748862 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT03748862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03748862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Primary Care Opioid Taper Plans and Their Components on Sustained Opioid Taper and Opioid Discontinuation
Lead sponsor
Kaiser Permanente
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
March 31, 2019
Enrollment
2,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opiate replacement therapy